Filter
4107
Filtered Results: 4107
Text search:
Epidemic
Infectious
Disease
Featured
Recommendations
405
New Publications
1090
Language
Document type
No document type
2319
Studies & Reports
661
Guidelines
604
Manuals
163
Strategic & Response Plan
157
Fact sheets
105
Situation Updates
38
Training Material
34
Infographics
14
Resource Platforms
8
Online Courses
2
Brochures
1
App
1
Countries / Regions
Global
166
Sierra Leone
146
Liberia
133
India
133
Kenya
102
Africa
87
Western and Central Europe
86
Ethiopia
83
South Africa
82
Nigeria
76
Uganda
76
Latin America and the Carribbean
74
Guinea
62
Zambia
62
Tanzania
62
Rwanda
61
Congo, Democratic Republic of
58
Nepal
55
Brazil
50
Mozambique
49
Russia
47
Ghana
45
Malawi
43
West and Central Africa
43
Namibia
38
Bangladesh
37
Ukraine
37
Eastern Europe
36
Asia
35
East and Southern Africa
34
South–East Asia Region
31
Senegal
30
Zimbabwe
30
Lesotho
29
Myanmar / Burma
29
Middle East and North Africa
29
Syria
26
Philippines
23
Germany
23
Cambodia
23
Haiti
21
South Sudan
21
Angola
20
Botswana
17
Yemen
17
Cameroon
16
Eastern Europe and Central Asia
15
Madagascar
14
Guinea-Bissau
13
Indonesia
13
Peru
13
Colombia
12
Venezuela
12
Burkina Faso
11
Côte d’Ivoire / Ivory Coast
11
Bolivia
11
Vietnam
11
Pakistan
10
Eswatini/ Swaziland
10
Albania
10
Mali
9
Somalia
9
Thailand
9
Western Pacific Region
9
Spain
9
Georgia
8
Chad
7
China
7
Central African Republic
7
Ecuador
7
Chile
7
Sudan
6
Benin
6
Laos
6
Portugal
6
Togo
5
Iraq
5
Jordan
5
Afghanistan
5
Argentina
5
Burundi
5
Paraguay
5
Southern Africa
5
Tajikistan
5
USA
4
Niger
4
Turkey
4
Armenia
4
Moldova
4
Saudi Arabia
3
Lebanon
3
Papua New Guinea
3
North Macedonia
3
Italy
3
Timor Leste/ East Timor
3
Iran
3
Japan
3
France
3
Gambia
2
Dominican Republic
2
Sri Lanka
2
Estonia
2
North America
2
Mauritius
2
Tunisia
2
Morocco
1
Egypt
1
Malaysia
1
Mauritania
1
Ireland
1
Singapore
1
Austria
1
Switzerland
1
Honduras
1
El Salvador
1
Greece
1
Mexico
1
Other region
1
Fiji
1
Bhutan
1
Poland
1
Djibouti
1
Canada
1
Bulgaria
1
Romania
1
Lithuania
1
Turkmenistan
1
Denmark
1
Belgium
1
United Kingdom
1
Belarus
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
1503
Clinical Guidelines
309
Public Health
199
Key Resources
144
Women & Child Health
106
Capacity Building
38
Pharmacy & Technologies
35
Annual Report MEDBOX
3
Toolboxes
COVID-19
634
HIV
550
TB
333
Ebola
287
Rapid Response
268
Planetary Health
110
NTDs
97
Mental Health
85
Zika
80
AMR
71
Global Health Education
69
Caregiver
63
Conflict
58
Cholera
55
Natural Hazards
49
NCDs
48
Refugee
46
Health Financing Toolbox
43
Polio
35
Pharmacy
28
Disability
17
Specific Hazards
16
Social Ethics
4
Typhoon
2
South Sudan
1
South Africa has faced many challenges over the past two decades, accomplishing profound positive changes in the social structure and government of the nation. This has not yet fully translated into better health for the population, however, particularly the poorest segment. In fact, the p...
Cases of monkeypox (MPX) acquired in the EU have recently been reported in nine EU Member States (Austria, Belgium, France, Germany, Italy, Portugal, Spain, Sweden, and the Netherlands).
Monkeypox (MPX) does not spread easily between people. Human-to-human transmission occurs through close contact ...
Pakistan Global Antibiotic Resistance Partnership (GARP) was formed in the wake of international and national efforts for AMR curtailment. A group of experts from microbiology, infectious ...s and veterinary medicine formed a core group at the organizational meeting of GARP in Kathmandu, Nepal in July 2016. In the meeting, this core group was expanded to include other members from different sectors with the selection of the Chair and co-chairs. These were asked to serve on a voluntary basis, in their own individual capacities, with no personal gains, or gains to the institutions to which they are affiliated. The first phase of GARP took place from 2009 to 2011 and involved four countries: India, Kenya, South Africa and Vietnam. Phase one culminated in the 1st Global Forum on Bacterial Infections, held in October 2011 in New Delhi, India. In 2012, phase two of GARP was initiated with the addition of working groups in Mozambique, Tanzania, Nepal and Uganda. Phase three has added Bangladesh, Lao PDR, Nigeria, Pakistan and Zimbabwe to the network to date.
This document provides an overview of key considerations for the provision of the HIV continuum of care in the context of displaced people from Ukraine in the EU/EEA. This document has two aims: firstly, to outline what is known of the Ukrainian HIV epidem..., and secondly, to use the HIV continuum of care as a framework to set out suggestions based on published evidence and expert opinion on the management of the HIV continuum of care, with special consideration for people living with HIV from Ukraine. The document will also address the needs of those at risk of acquiring HIV. The main findings of this document were presented during an ECDC webinar, ‘Key considerations on the continuum of HIV care for refugees from Ukraine,’ hosted on 19 May 2022.
Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like ... occurred in monkeys kept for research. The first human case was recorded in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries.
In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response.
As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa.
This guidance addresses rationale, risk-based scenarios, practical considerations prior to adoption of the self-testing products, quality assurance, safety and ethical considerations, and data management considerations for COVID-19 self-testing. The Africa CDC recommends the use of rapid antigen sel...
Reports of antimicrobial-resistant (AMR) microorganisms are increasing globally, threatening to render existing treatments ineffective against many infectious diseases. In Africa, AMR has already be...
Leptospirosis is an infectious disease caused by pathogenic organisms belonging to the genus Leptospira, that are transmitted directly or indirectly from animals to humans. Leptospirosis is a major ...
Cholera is an acute gastrointestinal infection caused by the bacterium Vibrio Cholerae serogroup O1 or O139, and is often linked to unsafe drinking water, lack of proper sanitation and personal hygiene. It adversely affects mostly the poor and vulne...
Tuberculosis (TB) is an infectious disease that usually affects the lungs, though it can affect any organ in the body. It can develop when bacteria spread through droplets in the air. TB can be fata...
For COVID-19, as for many infectious diseases, the true level of transmission is frequently underestimated because a substantial proportion of people with the ... are undetected either because they are asymptomatic or have only mild symptoms and thus typically fail to present at healthcare facilities. There may also be neglected or under-served segments of the population who are less likely to access healthcare or testing. Under-detection of cases may be exacerbated during an epidemic, when testing capacity may be limited and restricted to people with severe cases and priority risk groups (such as frontline healthcare workers, elderly people and people with comorbidities). Cases may also be misdiagnosed and attributed to other diseases with similar clinical presentation, such as influenza.
Differences in mortality between groups of people and countries are important proxy indicators of relative risk of death that guide policy decisions regarding scarce medical resource allocation during the ongoing COVID-19 pandemic. This document is intended to help countries estimate CFR and, if possible, IFR, as appropriately and accurately as possible, while accounting for possible biases in their estimation
The major areas of focus for the plan will be:
- Social mobilization and community empowerment (health promotion & education for disease prevention);
- Promotion of access to safe water, good sanitation and hygiene;
- Surveillance an...
- Social mobilization and community empowerment (health promotion & education for disease prevention);
- Promotion of access to safe water, good sanitation and hygiene;
- Surveillance an...
The socioeconomic factors and public health inadequacies that facilitated the rapid spread of this infection continue to exist. As it is a new and emerging disease it has not received sufficient cov...
COVID-19 is a serious disease and all people living with HIV should take all recommended preventive measures to minimize exposure to, and prevent infection by, the virus that causes COVID-19. As in ...
Introduction The novel Coronavirus (nCoV) epidemic in 2019 -2020 has recently emerged. The route of transmission is not totally known, although it is known that it can spread from person to person, and local health care systems may be ill-equipped t...
Infectious diseases, such as COVID-19, can have a significant impact on children’s and their caregivers’
wellbeing beyond the disease itself. ...
The Coronavirus Disease 2019 (COVID-19) has had a continuous and robust impact on world health. The resulting COVID-19 pandemic has had a devastating physical, mental and fiscal impact on the millions of people living with noncommunicable ...s (NCDs), as they have a higher risk of severe illness and death from COVID-19. COVID-19 has been associated with an
excess in all-cause and cardiovascular disease (CVD) mortality beyond that related to the infection itself and its immediate consequences. Studies in the
United Kingdom (UK) and United States of America (USA) have clearly shown increasing deaths from ischemic heart disease, stroke and hypertensive disease due to COVID-19. Overall, the impact has been greater in individuals with lower socioeconomic status, even in high income nations.
There is paucity of data on the burden and specific drivers operative in the pathogenesis of chronic obstructive pulmonary disease (COPD) in the African setting and populations. Lack of awareness and inadequate knowledge on the aetio-pathogenesis of...
Cholera epidemics continue to be a major public health problem in many countries around the
world. When epidemics strike, they can spread rapidly. The di... can also evolve quickly;
patients with severe disease can die of dehydration hours after showing the first symptoms of
cholera.
The epidemiology of the disease is mediated by the interaction of the parasite (trypanosome) with the vectors (tsetse flies), as well as with the human and animal hosts within a particular environment. Related to these interactions, the ... is confined in spatially limited areas called “foci”, which are located
in Sub-Saharan Africa, mainly in remote rural areas. The risk of contracting HAT is, therefore, determined by the possibility of contact of a human being with an infected tsetse fly. Epidemics of HAT were described at the beginning of the 20th century; intensive activities have been set up to confront the disease, and it was under control in the 1960s, with fewer than 5,000 cases reported in the whole continent.
